CROI 2017 Program and Information

Program and Agenda

Poster Sessions • Tuesday Carolina Fernández McPhee 1 , Talía Sainz 2 , Loreto Hierro 3 , Antoni Noguera-Julian 4 , Maria José Mellado 2 , Marta Montero 5 , María Isabel González-Tomé 6 , Paloma Jara 3 , Carmen Díaz 3 , Maria Luisa Navarro 1 1 Univ Hosp Gregorio Marañon, Madrid, Spain, 2 Hosp La Paz and IdiPAZ, Madrid, Spain, 3 Univ Hosp La Paz, Madrid, Spain, 4 Univ de Barcelona, Barcelona, Spain, 5 Hosp Univ y Politécnico La Fe, Valencia, Spain, 6 Univ Hosp 12 de Octubre, Madrid, Spain 528 THE ASSOCIATION BETWEENHCV AND COMORBID CONDITIONS IN2 LARGE PATIENT COHORTS Sarah E. Rowan 1 , Joshua Durfee 1 , David C. Tabano 2 , Suzanne Dircksen 1 , Edward Havranek 1 , Aimee Truesdale 1 , Arthur Davidson 1 1 Denver Hlth and Hosp Authority, Denver, CO, USA, 2 Kaiser Permanente Colorado, Denver, CO, USA 529 CAUSE &PREDICTORS OFMORTALITY IN ANHIV/HEPATITIS-C– COINFECTED COHORT IN SCOTLAND Rebecca Metcalfe 1 , Gordon Proctor 2 , Joe Schofield 3 , Emma Thomson 2 1 Brownlee Cntr for Infectious Diseases, NHS Greater Glasgow and Clyde, Glasgow, UK, 2 Univ of Glasgow, Glasgow, UK, 3 Pub Hlth Protection Unit, NHS Greater Glasgow and Clyde, Glasgow, UK 530 ADAR1 SNPS INVOLVED IN SEVERITY OF LIVER DISEASE INHIV/ HCV-COINFECTED PATIENTS Luz M. Medrano 1 , Amanda Fernández-Rodríguez 1 , Juan Berenguer 2 , María Á. Jimenez-Sousa 1 , Teresa Aldámiz-Echevarría 2 , Francisco Tejerina 2 , Cristina Diez 2 , Lorena Vigón 1 , Salvador Resino 1 , for the Institute of Health Carlos III (ISCII) 1 Inst of Hlth Carlos III, Madrid, Spain, 2 Hosp Gregorio Marañon, Madrid, Spain 531 CB2-RR VARIANT, LINKED TO LIVER DAMAGE INHIV/HCV CASES, MAY FAVOR HIV ACQUISITION Caterina Sagnelli 1 , Marco Merli 2 , Caterina Uberti-Foppa 2 , Giulia Bellini 1 , Hamid Hasson 2 , Nicola Coppola 1 , Adriano Lazzarin 2 , Evangelista Sagnelli 1 , Francesca Rossi 1 1 Second Univ of Naples, Naples, Italy, 2 San Raffaele Scientific Inst, Milan, Italy Poster P-L2 PROGRESSION OF LIVER DISEASE IN THE HCV-INFECTED POPULATION Poster Hall - 4 EF 2:30 PM - 4:00 PM 525 PROGRESSION OF LIVER FIBROSIS INHIV-MONOINFECTED ADULTSWITH ELEVATED TRANSAMINASES Rebecca Krakora 1 , Mary McLaughlin 2 , David E. Kleiner 3 , Nina Kvaratskhelia 1 , Raissa Canales Santos 4 , Colleen Hadigan 2 , Joseph A. Kovacs 1 , Theo Heller 4 , Caryn G. Morse 1 1 NIH, Bethesda, MD, USA, 2 NIAID, Bethesda, MD, USA, 3 NCI, Bethesda, MD, USA, 4 NIDDK, Bethesda, MD, USA 526 GUT EPITHELIAL DAMAGE, IMMUNE ACTIVATION& LIVER FIBROSIS INHIV AND HCV INFECTION Michael J. Reid 1 , Yifei Ma 1 , Rebecca Scherzer 1 , Jennifer Price 1 , Audrey French 2 , Michael Plankey 3 , Carl Grunfeld 1 , Phyllis Tien 1 1 Univ of California San Francisco, San Francisco, CA, USA 2 Rush Univ, Chicago, IL, USA, 3 Georgetown Univ, Washington, DC, USA 527 VERTICALLY HIV/HCV- VS HCV-INFECTED CHILDREN: HCV TREATMENT &PROGRESSION TO FIBROSIS

CROI 2017 94